Replies to post #136926 on Bioelectronics Corp (BIEL)

[Rheeper]

BIEL’s peak valuation (market cap) was $150m back in 8/2010. The share count was 1.47bn then.

[Investor100]

That is based upon a company back in 2009 whose product was in trials at that time.

Stock Valuation -- There are currently approximately 720 million outstanding shares, which represent a total market capitalization of approximately $7.2 million. Even though the price of BioElectronics Corp. shares has risen substantially over the past few weeks, the management team believes the stock is still significantly undervalued.


FDA Filings -- Early this week BioElectronics filed two applications with the FDA. The first of these was for 510(k) marketing clearance for its Allay Menstrual Pain Relief Patch product seeking OTC marketing clearance and an indication for pain reduction associated with dysmenorrhea (period pain and cramps). The second FDA filing was for a reclassification of the Company's technologies from Class III to Class II.

Biel is a much different company today as we all know from past PR's to the most recent meeting with the FDA and another on May 29th thus I know what I own and plan to ride this out to the end!

Investor 100